secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001641172-25-015242
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience Q3 net product sales up 11% YoY; net loss narrows to $580K
--------------------------------------------------------------------------

- Net product sales $489K in fiscal Q3 ended Apr 30, 2025, up from $440K YoY.
- Net loss improved to $580K from $857K in same quarter last year.
- Adjusted net loss (excl. share-based comp) was $547K vs $825K YoY.
- EPS remained ($0.01) for both quarters; nine-month EPS ($0.02) vs ($0.03) last year.
- CEO reports SDC dairy membrane solution now commercial at full-scale dairy plants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000164117225015242/0001641172-25-015242-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000164117225015242/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-015242

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer